PPARG and Alzheimer disease: The results collected so far from in vitro and in vivo models highlight the positive effects of PPARγ agonists in ameliorating cognitive performances in AD, and propose these drugs, or natural ligands of PPARγ, as future therapeutic approaches in cognitive impairment.